Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Phase II Study of Antineoplastons A19 and AS2-1 in Patients With Neurofibroma and Schwannoma
Brief Summary:
RATIONALE: Current therapies for adults with a recurrent/residual Neurofibroma or Schwannoma provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of adults with a recurrent/residual Neurofibroma or Schwannoma.
PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on adults with a recurrent/residual Neurofibroma or Schwannoma.